Actionable trade ideas with defined risk and time horizons.
Curated trade ideas across equities, options, and other instruments, featuring clear directional bias, time horizon, and risk considerations. Trade ideas are designed to align market context, technical structure, and risk management principles.
6,602 total articles
Grab trades near its 52-week low despite accelerating revenue and margin progress. With a $14.4B market cap, improving adjusted EBITDA and product momentum from recent AI initiatives, we like a mid-term long that pays off if mobility recovers or financial services continue to scale. Entry $3.50, stop $3.10, target $4.50 over 45 trading days.
British American Tobacco (BTI) looks attractively priced for an income-oriented long trade. At $65.35 the stock offers a c.4.7% yield, a 14x P/E and clear margin/cash generation to support dividends and buybacks while the business transitions to smoke-free formats. Technicals show bullish momentum and a reasonable risk/reward with a stop below $60.…
RTX offers a classic dual-cycle setup: a defensive tailwind from higher missile and air-defense demand plus a recovering commercial engine business. Valuation at ~33x 2026 EPS and an EV/EBITDA near 20 is full but not unreasonable given free cash flow of $8.46B. Trade plan: enter at $177.04, stop $165.00, target $205.00 over a mid-term (45 trading d…
TORM offers a rare combination for income-oriented traders: a >6% yield, activist/strategic shareholder activity and a valuation that reads cheap on simple multiples. Pair that with a recent stretch of operational outperformance and upcoming dividend flow and you have a tradeable long with clear entry, target and stop. This is a tactical position f…
TMC the metals company (TMC) is a high-risk, high-reward play on deep-sea polymetallic nodules that contain nickel, cobalt, copper and manganese. With a new Allseas contract, favorable regulatory momentum and a market cap of $2.34B that represents only a sliver of the company's cited NPV of its resources, now is an actionable dip to take a measured…
Immunovant (IMVT) is upgraded to Buy after recent evidence and corporate moves that increase the probability IMVT-1402 becomes a multi-indication FcRn franchise. The setup combines a crowded but expanding autoimmune market, upcoming near-term readouts (RA topline expected H2 2026) and improved technical momentum. This is a high-risk, potentially hi…
Ford's commercial arm, Ford Pro, is generating stable cash flow while management levers cost cuts and an emerging Ford Energy business provide re-rating catalysts. Valuation metrics (price-to-sales ~0.31, price-to-free-cash-flow ~6.2) leave room for upside if Ford can sustain margin improvement and monetize energy and BESS ambitions. We favor a mid…
NIO's latest quarter and delivery guidance point to improving unit economics. With a $12.6B market cap, elevated liquidity, and technicals near oversold, this is a pragmatic long trade: entry $5.20, stop $4.40, target $7.00 over a mid-term 45 trading day horizon.
Navios Maritime Partners (NMM) is trading below book with a market cap of $2.13B, single-digit P/E (6.3) and a large contracted revenue backlog. Combine that with bullish technicals and a recent bond program to shore up liquidity, and you get a mid-term trade with defined risk/reward: entry $74.50, target $88.00, stop $67.00 - horizon: mid term (45…
V2X (VVX) has been weighed down by a large private-equity shareholder exit. That overhang looks largely cleared after the March disposition, leaving a mid-cap defense contractor with a $4.6B multi-year contract, improving adjusted earnings and free cash flow. At $73.97 the stock trades at ~26x earnings and EV/EBITDA ~10x on a market cap of $2.32B. …
Apple's business is still huge and cash-generative, but market pricing and three structural risks - valuation stretchedness, AI & services disruption, and geopolitical/China fragility - create a viable path for AAPL to fall out of the Magnificent 7 by the end of 2030. This is a tactical short idea with a clear entry, stop, and target for a long-ter…
Teva is moving beyond a pure generics identity. A $700M acquisition of Emalex (ecopipam), a confirmed buyback and cost-savings plan, and visible cash generation create a tactical long opportunity into H2 2026 regulatory milestones. Trade plan with entry at $34.00, stop at $29.00 and target $42.00 for a long-term (180 trading days) horizon.
Etsy is showing the earliest signs of a structural recovery: mobile is nearing 50% of GMV with healthy growth, the core marketplace returned to positive GMS growth, and a $1.2B Depop divestiture meaningfully de-risks the balance sheet and enables buybacks. With free cash flow of $711M and a market cap near $5.92B, FCF yield is compelling; we lay ou…
Kirby Corporation is a cash-generative inland tank-barge operator with a distribution and power-generation aftermarket business that stands to benefit from accelerated data-center and digital infrastructure activity. Strong free cash flow, a shareholder-friendly repurchase program and a healthy balance sheet support a long trade at current levels. …
Vistra's combination of long-term data center contracts, solid free cash flow ($1.803B) and an EV/EBITDA of 10.9 give it tactical edge versus peers that are either more leveraged to commodity swings or slower to monetize AI-driven demand. This trade idea targets a mid-term swing capturing re-rating potential while keeping a tight stop for leverage …
SCZ, the iShares MSCI EAFE Small-Cap ETF, dipped recently but key technicals and yield profile make the risk/reward attractive. Market-cap $14.6B, a 2.6% dividend yield and a 30-day SEC yield of 2.04% help lower carry-adjusted downside while price sits near support. We lay out a mid-term (45 trading days) trade plan with entry, stop and target alon…
Nano Labs (NA) trades like a micro-cap semiconductor house with hybrid ambitions: fabless chips, AI hardware and an explicit pivot into crypto reserves. At a $57.3M market cap, the stock is cheap on headline multiples (P/E 2.6, P/B 0.53) while technicals show constructive momentum. This is a tactical long for traders willing to accept execution and…
Navios Maritime Partners (NMM) trades at just 0.63x book and a single-digit P/E while generating strong TCE and EBITDA trends. Technicals and short-interest dynamics point to asymmetric upside in the next 45 trading days, while bond issuance and steady distributions reduce near-term financing risk. We outline an actionable swing-long trade with exp…
Cast Advisers' Q1 2026 investor letter signals a cleaner earnings runway: higher fee capture, tighter cost control, and a resume of buybacks/insider purchases. We initiate a long position at $12.00 with a $18.00 target and a $9.00 stop, targeting a full-position hold over the next 180 trading days while monitoring quarterly AUM and fee trends.
Occidental is generating steady free cash flow, cutting leverage and sitting on a cyclical oil tailwind. With the stock trading at roughly $59, an attractive EV/EBITDA of 6.7 and free cash flow of about $3.6B, buying the common here is a pragmatic way to capture dividend yield, potential corporate optionality and a re-rating if oil stays elevated. …
Reddit is showing signs of re-entering growth mode as ad demand stabilizes and product fixes improve engagement. With limited near-term optimism priced in, this trade seeks a tactical long on a bounce prompted by improving ad CPMs, platform product rollouts, and the re-monetization of video and community tools.
Microsoft's core businesses are accelerating under an AI tailwind while balance-sheet strength and cash flow remain solid. The market has punished the stock on $190B-plus capex headlines, but valuation and fundamentals argue the bulk of that risk is priced in. This is a tactical long for disciplined traders looking to capture upside as AI monetizat…
Kinetik (KNTK) owns Permian-focused midstream logistics and pipeline transportation assets with attractive yield and a clear growth pipeline. The business is executing on new projects and recently raised its quarterly payout to $0.81, but free cash flow and balance-sheet metrics raise questions about distribution sustainability and valuation. This …
Uranium Royalty Corp. (UROY) trades like a beaten-down royalty vehicle with a market cap near $495M and a portfolio that can be amplified quickly through bolt-on royalty purchases. Near-term technical pressure masks a simple risk-reward: modest capital outlays for royalties can lead to large optionality if uranium fundamentals and consolidation acc…
Taiwan Semiconductor (TSM) sits at the center of the AI hardware supply chain. With ~72% pure-play foundry share, aggressive 2nm capacity plans, and a customer mix that includes every major GPU and custom AI chip designer, TSM is positioned to capture outsized share of the AI capex cycle. We reiterate Buy with a clear trade plan: entry $404.43, sto…
